|
Residency Training
in Neurosurgery - Research
Residents | Residency
Program | Education
Links | Fellowships
| Alumni
GENERAL DESCRIPTION
The length of the Training Program
is six or six-and-a-half years. This consists of five years of required
residency with an additional 12-18 months of expanded training.
There are 36 months of clinical neurological surgery. The five years
of Residency Training consist of seven six-month clinical rotations
and 18 months of laboratory research. The mandatory research period
occurs as a single time block between the Senior clinical rotations.
Following the year of Chief Residency, each trainee has an additional
six months of the expanded clinical training as Assistant in Neurosurgery
at the MGH. In addition there are 6-12 months of expanded training
in laboratory research This expanded period of research occurs either
just prior to the trainee's first clinical rotation or in conjunction
with the required research block. The trainee has no clinical responsibilities
during the research period.
Residency applications are processed
solely through the Neurological Surgery Matching Program. Applicants
must be graduates of a medical school accredited by The American
Association of Medical Colleges. Two candidates are typically selected.
The Residency in Neurosurgery at MGH follows a uniform pattern of
six years of increasing responsibility beginning after a one year
surgical internship. Entering residents are strongly encouraged
to complete their PGY-1 surgical training at the Massachusetts General
Hospital and separate application is required through the Department
of Surgery. Both trainees begin their neurosurgical training on
July 1. One of the trainees immediately enters the first clinical
rotation; the other initially pursues a period of laboratory based
research prior to their first clinical work.
The sequence of rotations is designed
to provide the trainee with clinical experience of graded and increasing
complexity with responsibilities commensurate with their level of
training. In addition to their responsibilities for in-patient and
Emergency Ward care, all residents on clinical rotations participate
in the Neurosurgical Outpatient Clinic one day a week. With the
exception of a three-month rotation at Boston Children's Hospital
at the Junior Resident level, all clinical assignments are at MGH.
The trainees follow the fixed sequence of rotations described below
and finish the program at six month intervals in either June or
December, following their year of Chief Residency.
For purposes of coordinating Neurosurgical
Service activities Visiting Staff members are assigned to a clinical
team (East or West). The order of trainee assignments is such that
he/she rotates through all Service teams, thus coming under the
supervision of all members of the Visiting Staff. In the final six
months of the Chief Resident year, the trainee is directly supervised
by the Chief of Service, Dr. Martuza. Thereafter, the graduating
Resident completes his/her six months or more of extended clinical
training with a Staff appointment at the parent institution. During
that period, he/she is responsible for the clinical activities of
the North neurosurgical team.
The trainee has no clinical responsibilities
during the research period. For more information, see: residents.neurosurgery.mgh.harvard.edu
MAJOR RESEARCH PROJECTS
Trainees within the Neurosurgical Service have access to any of
the laboratories within the Harvard University System. These include
all of the major current areas of research in neurobiology, as well
as cell and molecular biology.
Within the Department of Neurosurgery
itself, the research activities can be grouped in 5 major areas:
Cerebral Blood Vessels
Blood vessels are being studied from several perspectives. A major
research program concerns the biology of cerebral stroke. Research
in this area includes studies on imaging of cerebral blood flow
with a variety of
modern imaging techniques. A basic laboratory program studies
in vitro systems toward the goal of learning what might protect
nervous tissue from interruptions of its supply of glucose and
oxygen. Neuroprotective agents such as cooling and neurotransmitter
antagonists are currently under study. In addition, laboratory
studies aimed at extending the in vitro studies to the in vivo
situation are carried out. Commonly ischemia is caused in a neural
region, and agents that might reduce the severity of the infarct
are tested. These studies have led to introduction of certain
therapeutic maneuvers in the operating room, notably mild cooling
in patients whose cerebral circulation must be interrupted for
surgical reasons.
A major research area concerns the biology of headache. In the
laboratory, the innervation of the blood vessels has been intensively
studied. The sequence of events attending migraine have been delineated
using extravasation of tracers as a marker. A new series of anti-migraine
drugs is being developed and tested both in vitro and in vivo.
A major laboratory studies cerebral vasospasm. In the laboratory,
isolated dog arteries are perfused in vitro and the factors that
constrict and relax them are studied. In vivo, vasospasm may be
experimentally induced in dogs by subarachnoid injection of blood.
This provides a model in which to test potential maneuvers aimed
at reducing the spasm. Recently, a major collaboration with the
MGH Laser Laboratories has resulted in a potential new therapeutic
invention. High intensity laser pulses are applied at the site
of spasm. In dogs, these succeed in relaxing the vessel. Phase
1 trials of this intervention are being planned.
Neural Growth and Regeneration
A major long-term goal for Neurosurgery is the restoration of
damage of function that has been lost due to damage to the nervous
system. Two research areas aim toward that goal.
Work carried out in collaboration with the Department of Neurology
involves the attempt to implant cultured neurons into the brains
of animals following experimentally induced brain damage. The
basal ganglia are the
focus of this work and dopamine-releasing neurons are being implanted
into the brain following experimental lesions of the dopamine-containing
brain neurons. Similar strategies can be applied to other brain
models.
On the more fundamental level, we are trying to learn the factors
that promote the growth of neurons. This is being carried out
using cultured cells. A new factor released by immortalized cultured
glia has been discovered. It promotes a neurite outgrowth from
a variety of projection neurons. Current studies are aimed at
identifying and cloning the factor.
Brain Tumors
The natural history of brain tumors is being studied in collaboration
with the Department of Pathology. This work focuses on the mutation
or series of mutations that occur in glioblastomas. This work
concentrates on the
use of PPCR methodologies to amplify the DNA of biopsy specimens
and of archival neuropathology slides. The latter are particularly
useful since the outcome is known. A series of mutations have
been found to occur in
naturally occurring brain tumors. Many tumors have a mutation
of the p53 gene. Another common mutation is amplification of the
EGFR (epidermal growth factor receptor) gene.
A second area of brain tumor research is the use of retroviral
therapy against glioblastomas. The goal is to use retroviruses
to introduce into the tumors genes that would either kill the
tumor cells, later their pattern of growth, or sensitize them
to chemotherapeutic agents. One such trial involves the introduction
of a gene for thymidine kinase. A number of analogous manipulations
are being tested both vitro and in rats.
Intraoperative Monitoring and Imaging
A major area of clinical research concerns surgery for epilepsy.
Candidates for epilepsy surgery are intensively studied by electrophysiological
and imaging techniques. Electrophysiologically, implanted electrodes
are used to monitor seizure activity in awake patients. PET imaging
is used to localize motor and language areas. New technology allows
superimposition of the PET images with MRI scans, providing sharply
defined landmarks during surgery. A further area of exploration
is the use of virtual imaging in the operating room.
Cellular Neurobiology
Within the Department of Neurosurgery there are also laboratories
of fundamental neurobiology. These are concerned with various
aspects of neuroanatomy and neurophysiology.
One area of focus is the cell biology
of the retina. The retina is used as a model system for studies
of how small neural networks operate computationally upon their
inputs. This laboratory uses anatomical methods and combined anatomy/physiology
studies of in vitro retinas.
Another area of research concerns the biology of membrane proteins,
particularly the Na,K-ATPase. These studies are aimed at understanding
the heterogeneity of the Na,K-ATPases in the brain and their regulation.
|
|
Neurosurgery
Clinical Units
|
|
|